Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash stock-based compensation expenses of $397 and $489, respectively) 1,552 1,349
General and administrative expenses (including non-cash stock-based compensation expenses of $658 and $771, respectively) 1,834 2,260
Total operating costs and expenses 3,386 3,609
Loss from operations (3,386) (3,609)
Interest income 173 319
Net loss (3,213) (3,290)
Less: Net loss attributable to noncontrolling interest (29) (35)
Net loss attributable to common shareholders $ (3,184) $ (3,255)
Net loss per common share attributable to common shareholders:    
Basic $ (0.10) $ (0.10)
Diluted $ (0.10) $ (0.10)
Weighted average common shares outstanding:    
Basic 32,197 31,446
Diluted 32,197 31,446